# Comparison of Adenine-Induced Rat Models for Vascular Calcification in Chronic Kidney Disease

## TL;DR

This study found a reliable way to create a rat model for vascular calcification in chronic kidney disease by adjusting adenine doses over time.

## Contribution

A new adenine dosing protocol that induces vascular calcification with high success and acceptable survival in rats.

## Key findings

- A 12-week high-dose adenine followed by 6 weeks of low-dose adenine induced vascular calcification in 66.7% of rats.
- This method maintained a 75% survival rate, making it more practical than continuous high-dose adenine.
- Lower-dose or shorter-duration protocols resulted in minimal or no calcification.

## Abstract

People with chronic kidney disease often suffer from a dangerous condition where calcium builds up in their blood vessels. This can lead to serious problems like heart disease or the need to amputate limbs. To find better treatments, scientists need reliable ways to study this condition. In this study, we tested different ways to feed rats a substance called adenine, which can damage the kidneys and mimic the disease seen in humans. We tried various amounts and feeding periods to see which method would cause calcium to build up in the blood vessels, while still keeping the animals healthy enough to study. We found that giving rats a higher dose for 12 weeks, followed by a lower dose for 6 weeks, led to a strong calcium buildup with fewer deaths. This approach gives researchers a new and effective way to study blood vessel disease linked to kidney problems. Understanding this process in animals can help scientists develop better treatments and prevention strategies for people in the future.

Vascular calcification significantly contributes to cardiovascular complications and limb loss in chronic kidney disease (CKD). To establish an optimal rat model for vascular calcification, we tested varying adenine concentrations and feeding durations in Sprague–Dawley rats (n = 72), divided into six groups (n = 12 each). The control group received a standard diet for 18 weeks. Group 1 was given 0.5% adenine for 4 weeks, followed by a standard diet. Group 2 received 0.5% adenine for 4 weeks, then 0.25% for 14 weeks. Group 3A received 0.5% adenine for 12 weeks and then standard diet; group 3B received 0.5% adenine for 12 weeks, followed by 0.25% for 6 weeks; group 3C received 0.5% adenine for 18 weeks. At week 18, vascular calcification was absent in the control and group 1. Groups 2 and 3A showed low incidence (12.5%), while groups 3B and 3C showed high incidence (66.7%). However, survival rates differed: 75.0% in 3B and 50.0% in 3C after 12 wk. Thus, 0.5% adenine for 12 weeks followed by 0.25% for 6 weeks effectively induced vascular calcification while maintaining acceptable survival, providing a practical model for studying CKD-related vascular pathology.